Skip to main content

Advertisement

SpringerLink
Log in

Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Atopic dermatitis, allergic rhinitis, and bronchial asthma are allergic immune disorders characterized by a predominance of T helper 2 (Th2) cells, the resulting elevation of allergen-speci.c immunoglobulin E (IgE), and mast cell- and eosinophil-associated inflammation. The cytokine environment at the site of the initial antigen stimulation determines the direction of helper T-cell differentiation into Th1 or Th2 cells. Therefore, negative regulators of cytokine signaling, suppressors of cytokine signaling (SOCS) proteins, play an important role in Th2-mediated allergic responses through the control of the balance between Th1 and Th2 cells. SOCS3 and SOCS5 are predominantly expressed in Th2 and Th1 cells, respectively, and they reciprocally inhibit the Th1 and Th2 differentiation processes. In this article, we discuss the role of SOCS3 and SOCS5 proteins in atopic asthma and allergic conjunctivitis and explore the potential of SOCS proteins as targets for therapeutic strategies in allergic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255–281.

    Article  PubMed  CAS  Google Scholar 

  2. Burrows B, Martinez FD, Halonen M, et al.: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989, 320:271–277.

    Article  PubMed  CAS  Google Scholar 

  3. Martinez FD, Wright AL, Taussig LM, et al.: Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995, 332:133–138.

    Article  PubMed  CAS  Google Scholar 

  4. Arima K, Umeshita-Suyama R, Sakata Y, et al.: Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002, 109:980–987.

    Article  PubMed  CAS  Google Scholar 

  5. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergenspecific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999, 103:175–183.

    Article  PubMed  CAS  Google Scholar 

  6. O’Shea JJ, Gadina M, Schreiber RD 2002. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002, 109(Suppl):S121-S131.

    Article  PubMed  CAS  Google Scholar 

  7. Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002, 2:410–416. This is a review article summarizing the history and the functional signi.cance of SOCS family proteins in in vitro insight.

    PubMed  CAS  Google Scholar 

  8. Greenhalgh CJ, Miller ME, Hilton DJ, Lund PK: Suppressors of cytokine signaling: relevance to gastrointestinal function and disease. Gastroenterology 2002, 123:2064–2081.

    Article  PubMed  CAS  Google Scholar 

  9. Ihle JN: Cytokine receptor signalling. Nature 1995, 377:591–594.

    Article  PubMed  CAS  Google Scholar 

  10. Yasukawa H, Sasaki A, Yoshimura A: Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000, 18:143–164.

    Article  PubMed  CAS  Google Scholar 

  11. Zhang JG, Farley A, Nicholson SE, et al.: The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 1995, 96:2071–2081.

    Article  Google Scholar 

  12. Kamura T, Sato S, Haque D, et al.: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 1998, 12:3872–3881.

    PubMed  CAS  Google Scholar 

  13. Yoshimura A, Ohkubo T, Kiguchi T, et al.: A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995, 14:2816–2826.

    PubMed  CAS  Google Scholar 

  14. Matsumoto A, Seki Y, Kubo M, et al.: Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol 1999, 19:6396–6407.

    PubMed  CAS  Google Scholar 

  15. Naka T, Narazaki M, Hirata M, et al.: Structure and function of a new STAT-induced STAT inhibitor. Nature 1997, 387:924–929.

    Article  PubMed  CAS  Google Scholar 

  16. Starr R, Willson TA, Viney EM, et al.: A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917–921.

    Article  PubMed  CAS  Google Scholar 

  17. Endo TA, Masuhara M, Yokouchi M, et al.: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997, 387:921–924.

    Article  PubMed  CAS  Google Scholar 

  18. Yasukawa H, Misawa H, Sakamoto H, et al.: The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999, 18:1309–1320.

    Article  PubMed  CAS  Google Scholar 

  19. Giordanetto F, Kroemer RT: A three-dimensional model of suppressor of cytokine signalling 1 (SOCS-1). Protein Eng 2003, 16:115–124.

    Article  PubMed  CAS  Google Scholar 

  20. Nicholson SE, De Souza D, Fabri LJ, et al.: Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A 2000, 97:6493–6498.

    Article  PubMed  CAS  Google Scholar 

  21. Lehmann U, Schmitz J, Weissenbach M, et al.: SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem 2003, 278:661–671.

    Article  PubMed  CAS  Google Scholar 

  22. Sasaki A, Yasukawa H, Shouda T, et al.: CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 2000, 275:29338–29347.

    Article  PubMed  CAS  Google Scholar 

  23. Frantsve J, Schwaller J, Sternberg DW, et al.: Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol 2001, 21:3547–3557.

    Article  PubMed  CAS  Google Scholar 

  24. Kamizono S, Hanada T, Yasukawa H, et al.: The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 2001, 276:12530–12538.

    Article  PubMed  CAS  Google Scholar 

  25. Zhang JG, Metcalf D, Rakar S, et al.: The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc Natl Acad Sci U S A 2001, 98:13261–13265.

    Article  PubMed  CAS  Google Scholar 

  26. Kubo M, Hanada T, Yoshimura A: Suppressors of cytokine signaling and immunity. Nat Immunol 2003, 4:1169–1176. This is a review article summarizing the functional signi.cance of SOCS family proteins in several inflammatory diseases.

    Article  PubMed  CAS  Google Scholar 

  27. Hilton DJ: Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999, 55:1568–1577.

    Article  PubMed  CAS  Google Scholar 

  28. Fujimoto M, Naka T: Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003, 24:659–666.

    Article  PubMed  CAS  Google Scholar 

  29. Cohney SJ, Sanden D, Cacalano NA, et al.: SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol 1999, 19:4980–4988.

    PubMed  CAS  Google Scholar 

  30. Bjorbaek C, Elmquist JK, Frantz JD, et al.: Identi.cation of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998, 1:619–625.

    Article  PubMed  CAS  Google Scholar 

  31. Ito S, Ansari P, Sakatsume M, et al.: Interleukin-10 inhibits expression of both interferon alpha-and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999, 93:1456–1463.

    PubMed  CAS  Google Scholar 

  32. Auernhammer CJ, Melmed S: Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology 1999, 140:1559–1566.

    Article  PubMed  CAS  Google Scholar 

  33. Suzuki A, Hanada T, Mitsuyama K, et al.: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 2001, 193:471–481.

    Article  PubMed  CAS  Google Scholar 

  34. Yoshimura A, Mori H, Ohishi M, et al.: Negative regulation of cytokine signaling in.uences inflammation. Curr Opin Immunol 2003, 15:704–708.

    Article  PubMed  CAS  Google Scholar 

  35. Yasukawa H, Yajima T, Duplain H, et al.: The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 2003, 111:469–478.

    Article  PubMed  CAS  Google Scholar 

  36. Egwuagu CE, Yu CR, Zhang M, et al.: Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002, 168:3181–3187.

    PubMed  CAS  Google Scholar 

  37. Seki Y, Inoue H, Nagata N, et al.: SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med 2003, 9:1047. This paper clearly demonstrated pathological importance of SOCS3 in allergic disease and a role as negative regulator for IL-12 mediated Th1 differentiation.

    Article  PubMed  Google Scholar 

  38. Can.eld S, Lee Y, Schroder A, Rothman P: Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J Immunol 2005, 174:2494–2498.

    Google Scholar 

  39. Yamamoto K, Yamaguchi M, Miyasaka N, Miura O: SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. Biochem Biophys Res Commun 2003, 310:1188–1193.

    Article  PubMed  CAS  Google Scholar 

  40. Owaki T, Yoshimoto T: IL-27 suppresses CD28-mediated IL-2 production through SOCS3. J Immunol, In press.

  41. Takatori H, Nakajima H, Kagami S, et al.: Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression. J Immunol 2005, 174:4105–4112.

    PubMed  CAS  Google Scholar 

  42. Matsumoto A, Seki Y, Watanabe R, et al.: A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med 2003, 197:425–436.

    Article  PubMed  CAS  Google Scholar 

  43. Miyazaki Y, Inoue H, Matsumura M, et al.: Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-de.cient mice. J Immunol 2005, 175:2401–2407.

    PubMed  CAS  Google Scholar 

  44. Arakawa S, Hatano Y, Katagiri K: Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin Exp Immunol 2004, 135:505–510.

    Article  PubMed  CAS  Google Scholar 

  45. Ozaki A, Seki Y, Fukushima A, Kubo M: The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS) 3 and SOCS5. J Immunol 2005, 175:5489–5497. This work directly shows the possibility of modi.cation of SOCS function and expression as a therapeutic candidate.

    PubMed  CAS  Google Scholar 

  46. Huang H, Paul WE: Impaired interleukin 4 signaling in T helper type 1 cells. J Exp Med 1998, 187:1305–1313.

    Article  PubMed  CAS  Google Scholar 

  47. Kubo M, Ransom J, Webb D, et al.: T-cell subset-speci.c expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J 1997, 16:4007–4020.

    Article  PubMed  CAS  Google Scholar 

  48. Seki Y, Hayashi K, Matsumoto A, et al.: Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 2002, 99:13003–13008.

    Article  PubMed  CAS  Google Scholar 

  49. Brender C, Columbus R, Metcalf D, et al.: SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function. Mol Cell Biol 2004, 24:6094–6103.

    Article  PubMed  CAS  Google Scholar 

  50. Inoue H, Kubo M: SOCS proteins in T helper cell differentiation: implications for allergic disorders? Expert Rev Mol Med 2004, 6:1–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Signal Network, RIKEN Research Center for Allergy and Immunology (RCAI), RIKEN Yokohama Institute, Suehiro-cho 1-7-22, Tsurumi, Yokohama, 230-0045, Kanagawa, Japan

    Masato Kubo PhD

Authors
  1. Masato Kubo PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiromasa Inoue MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masato Kubo PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubo, M., Inoue, H. Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia. Curr Allergy Asthma Rep 6, 32–39 (2006). https://doi.org/10.1007/s11882-006-0007-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-006-0007-6

Keywords

Search

Navigation